Table 1. (A) Number of women from England and Wales reporting breast, bowel or lung cancer diagnosis between 1995 and 2007 who had relevant cancer; (B) in women who self-reported more than one of these cancers.
| (A) | |||
|---|---|---|---|
| ICD-9 and ICD-10 codes | No. of women with CR | % Concordance | 95% CI |
|
Self-reported cancer history | |||
|
Breast cancer (n=5210)a | |||
| C50/174 CR | 4358 | 83.6 | 82.6–84.6% |
| D05/233 CR |
578 |
11.1 |
10.3–12.0% |
| Total (invasive Br Ca+in situ carcinoma) |
4936 |
94.7 |
94.1–95.3% |
|
Bowel cancer (n=618) | |||
| C18/C19/C20/C21/C17/153/154 CRb (includes D01 in situ carcinoma) |
526 |
85.1 |
82.1–87.8% |
|
Lung cancer (n=89) | |||
| C33/C34/162 CR | 76 | 85.4 | 76.3–92.0% |
| | |||
| (B) | |||
|
ICD-9 and ICD-10 codes |
No. of women with CR |
% Agreement |
95% CI |
|
Breast cancer (n=5274)a | |||
| C50/174 CR | 4389 | 84.2 | 82.6–84.6% |
| D05/233 CR |
582 |
11.2 |
10.3–12.0% |
| Total (invasive Br Ca+in situ carcinoma) |
4971 |
94.3 |
94.1–95.3% |
|
Bowel cancer (n=669) | |||
| C18/C19/C20/C21/C17/153/154 CRb (includes D01 in situ carcinoma) |
559 |
83.6 |
81.7–87.5% |
|
Lung cancer (n=125) | |||
| C33/C34/162 CR | 81 | 64.8 | 76.3–92.0% |
Abbreviations: Br Ca= Breast cancer; CI=confidence interval; CR=cancer registry; DCIS=ductal carcinoma in situ; ICD-9; ICD-10=international causes of diseases and health-related problems (9th and 10th revision).
a
One woman did not give permission to ONS flagging.
b
Includes two women with C17..
The numbers/percentages in bold represent the results per breast (overall), bowel and lung cancer separately.